Article Versions Notes

Kim S, Rahim MA, Tajdozian H, Barman I, Park H-A, Yoon Y, Jo S, Lee S, Shuvo MSH, Bae SH, et al. Clinical Potential of Novel Microbial Therapeutic LP51 Based on Xerosis-Microbiome Index. Cells. 2024; 13(23):2029. https://doi.org/10.3390/cells13232029

Kim, Sukyung, Md Abdur Rahim, Hanieh Tajdozian, Indrajeet Barman, Hyun-A Park, Youjin Yoon, Sujin Jo, Soyeon Lee, Md Sarower Hossen Shuvo, Sung Hae Bae, and et al. 2024. "Clinical Potential of Novel Microbial Therapeutic LP51 Based on Xerosis-Microbiome Index" Cells 13, no. 23: 2029. https://doi.org/10.3390/cells13232029

Kim, S., Rahim, M. A., Tajdozian, H., Barman, I., Park, H.-A., Yoon, Y., Jo, S., Lee, S., Shuvo, M. S. H., Bae, S. H., Lee, H., Ju, S., Park, C.-e., Kim, H.-K., Han, J. H., Kim, J.-W., Yoon, S. g., Kim, J. H., Choi, Y. G., ... Song, H.-Y. (2024). Clinical Potential of Novel Microbial Therapeutic LP51 Based on Xerosis-Microbiome Index. Cells, 13(23), 2029. https://doi.org/10.3390/cells13232029